Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Would be nice to see Egrifta mentioned in this article
View:
Post by SPCEO1 on Feb 29, 2024 12:34pm

Would be nice to see Egrifta mentioned in this article

In the post-Viking environment and with XBI on a big run, it would no doubt propel the THTX stock price quite a bit. 

https://www.msn.com/en-us/health/other/weight-loss-drugs-have-one-big-problem-these-drugmakers-are-taking-it-on/ar-BB1iLJuB?ocid=socialshare
Comment by Trogarzon on Feb 29, 2024 12:48pm
Last call Mr Marketing did ditch the fatbuster rethoric for the muscle building one in his concluding remarks.
Comment by Trogarzon on Feb 29, 2024 12:56pm
It's all riding on F8.  How can you sell an indication for an unpatented drug. The only reason there's no copycat yet is the insignificance of the adressable market for now.
Comment by SPCEO1 on Feb 29, 2024 2:13pm
I suspect they ahve more options than we realize on the patent front.Also, Dr. Grinspoon did get them patent protection to 2039 or 2040 on some new indication which might work for them.
Comment by Mannequin on Feb 29, 2024 2:34pm
We need some good news for once. Is that possible please?  Throw us a friggen bone. 
Comment by Trogarzon on Feb 29, 2024 2:41pm
They did have a paratohormone patch with Alza that they sold to J&J back in the days.  I mean the days way back.  Talking about bones.
Comment by Trogarzon on Feb 29, 2024 2:43pm
Yeah they got 12M usd 20 years ago for it.  Today they get that for 25% of the company from IQ.. 20 years later.... lol
Comment by Trogarzon on Feb 29, 2024 3:26pm
The GLP1 mulscle wasting issues look appealing for Egrifta's proposition.  They did studies on COPD wasting back in the days too... wonder drug.... like aspirin...
Comment by Trogarzon on Feb 29, 2024 3:32pm
They even had a photodynamis printer for ex vivo cancer cell treatment... you could write a book on this company.  They a dentist solution to desinfect their stuff.. crazy....
Comment by Trogarzon on Feb 29, 2024 3:33pm
Like a billion of R&D for this... 
Comment by Trogarzon on Feb 29, 2024 3:36pm
Remenber Sakai chemicals and their ugly gift (a plaster head) and the pizza cell painting in the lobby...  lol.. memories...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities